- Home
- LWAY vs RNAC Comparison
LWAY vs RNAC Comparison
Compare LWAY & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LWAY
- RNAC
- Stock Information
- Founded
- LWAY 1986
- RNAC 2007
- Country
- LWAY United States
- RNAC United States
- Employees
- LWAY N/A
- RNAC N/A
- Industry
- LWAY Packaged Foods
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- LWAY Consumer Staples
- RNAC Health Care
- Exchange
- LWAY Nasdaq
- RNAC Nasdaq
- Market Cap
- LWAY 376.4M
- RNAC 316.1M
- IPO Year
- LWAY 1987
- RNAC 2016
- Fundamental
- Price
- LWAY $26.47
- RNAC $13.33
- Analyst Decision
- LWAY Hold
- RNAC Strong Buy
- Analyst Count
- LWAY 1
- RNAC 5
- Target Price
- LWAY N/A
- RNAC $40.00
- AVG Volume (30 Days)
- LWAY 45.8K
- RNAC 83.7K
- Earning Date
- LWAY 08-12-2025
- RNAC 08-07-2025
- Dividend Yield
- LWAY N/A
- RNAC N/A
- EPS Growth
- LWAY N/A
- RNAC N/A
- EPS
- LWAY 0.67
- RNAC N/A
- Revenue
- LWAY $188,277,000.00
- RNAC $34,173,000.00
- Revenue This Year
- LWAY $12.53
- RNAC N/A
- Revenue Next Year
- LWAY $12.08
- RNAC N/A
- P/E Ratio
- LWAY $38.59
- RNAC N/A
- Revenue Growth
- LWAY 12.84
- RNAC 31.91
- 52 Week Low
- LWAY $10.06
- RNAC $8.46
- 52 Week High
- LWAY $27.29
- RNAC $26.50
- Technical
- Relative Strength Index (RSI)
- LWAY 65.90
- RNAC 60.40
- Support Level
- LWAY $24.40
- RNAC $11.80
- Resistance Level
- LWAY $27.00
- RNAC $13.91
- Average True Range (ATR)
- LWAY 0.80
- RNAC 1.10
- MACD
- LWAY 0.11
- RNAC 0.03
- Stochastic Oscillator
- LWAY 80.37
- RNAC 53.04
About LWAY Lifeway Foods Inc.
Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir which is a cultured dairy product. Its product categories are Drinkable Kefir which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir and Other dairy. The company manufacture and market products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through direct sales force, brokers, and distributors.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.